Earnings · China A-shares
Yifan Pharmaceutical Co., Ltd. Class A (002019) earnings
Yifan Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-23: net profit -23.42% year on year, -7.33% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -1.28% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-23
- Period end
- 2026-09-30
- Net profit YoY
- -23.42%
- Excl. one-offs YoY
- -7.33%
- Net profit QoQ
- -6.36%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +0.85% | — |
| 3 days | -1.28% | — |
| 7 days | +0.53% | — |
| 14 days | -1.39% | — |
Report history
Over the last 8 reports, net profit grew year on year in 5 of them. The stock rose in the 3 trading days after 1 of 7 reports (average -1.29%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-24 | ¥296.98M | -23.42% | -7.33% | -5.13% | 0.24 | 3.32% | -1.28% | — | — |
| 2026 interim report | 2026-08-29 | ¥205.03M | -32.48% | -14.43% | -6.36% | 0.17 | 2.30% | -2.29% | -7.58% | +1.76% |
| 2026 Q1 report | 2026-04-24 | ¥106.83M | -30.25% | +9.16% | -5.36% | 0.09 | 1.21% | -4.17% | -16.26% | -16.67% |
| 2025 annual report | 2026-04-24 | ¥402.02M | +4.16% | +30.92% | -0.52% | 0.33 | 4.64% | -4.17% | -16.26% | -16.67% |
| 2025 Q3 report | 2025-10-31 | ¥387.79M | +5.84% | +25.17% | +1.67% | 0.32 | 4.44% | -0.47% | -3.90% | +0.79% |
| 2025 interim report | 2025-08-15 | ¥303.65M | +19.91% | +32.21% | +0.11% | 0.25 | 3.49% | +2.88% | -8.04% | -18.33% |
| 2025 Q1 report | 2025-04-30 | ¥153.16M | +4.83% | -13.55% | +0.05% | 0.13 | 1.78% | -2.91% | +23.27% | +20.09% |
| 2024 annual report | 2025-04-28 | ¥385.97M | +170.04% | +146.58% | +26.84% | 0.32 | 4.48% | -0.79% | +25.28% | +22.04% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.